These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 2738260
21. Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study. Kim SG, Aboaf AP, Roth J, Ferrick K, Fisher JD. Am Heart J; 1991 Jan; 121(1 Pt 1):77-80. PubMed ID: 1985381 [Abstract] [Full Text] [Related]
22. Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function. Spielman SR, Greenspan AM, Kay HR, Discigil KF, Webb CR, Sokoloff NM, Rae AP, Morganroth J, Horowitz LN. J Am Coll Cardiol; 1985 Jul; 6(1):31-40. PubMed ID: 4008786 [Abstract] [Full Text] [Related]
23. Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing. Gonska BD, Bethge KP, Kreuzer H. Clin Cardiol; 1987 May; 10(5):294-304. PubMed ID: 3594942 [Abstract] [Full Text] [Related]
24. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. N Engl J Med; 1999 Dec 16; 341(25):1882-90. PubMed ID: 10601507 [Abstract] [Full Text] [Related]
25. Management of nonsustained ventricular tachycardia guided by electrophysiological testing. Kadish A, Schmaltz S, Calkins H, Morady F. Pacing Clin Electrophysiol; 1993 May 16; 16(5 Pt 1):1037-50. PubMed ID: 7685883 [Abstract] [Full Text] [Related]
26. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Lampert S, Lown B, Graboys TB, Podrid PJ, Blatt CM. Am J Cardiol; 1988 Apr 01; 61(10):791-7. PubMed ID: 3354443 [Abstract] [Full Text] [Related]
29. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW. N Engl J Med; 1993 Aug 12; 329(7):445-51. PubMed ID: 8332149 [Abstract] [Full Text] [Related]
31. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing. Rae AP, Kay HR, Horowitz LN, Spielman SR, Greenspan AM. J Am Coll Cardiol; 1988 Jul 01; 12(1):131-9. PubMed ID: 3379198 [Abstract] [Full Text] [Related]
32. Results of electrophysiologic testing and long-term prognosis in patients with coronary artery disease and aborted sudden death. Sousa J, Rosenheck S, Calkins H, de Buitleir M, Schmaltz S, Kadish A, Morady F. Am Heart J; 1991 Oct 01; 122(4 Pt 1):1001-6. PubMed ID: 1927851 [Abstract] [Full Text] [Related]
33. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. N Engl J Med; 2000 Jun 29; 342(26):1937-45. PubMed ID: 10874061 [Abstract] [Full Text] [Related]
34. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Horowitz LN, Greenspan AM, Spielman SR, Webb CR, Morganroth J, Rotmensch H, Sokoloff NM, Rae AP, Segal BL, Kay HR. Am J Cardiol; 1985 Feb 01; 55(4):367-71. PubMed ID: 3969870 [Abstract] [Full Text] [Related]
35. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia. Estes NA, Gold R, Cameron J, Haffajee C, Marshall M, Mack K, Salem DN. Am J Cardiol; 1987 Jun 15; 59(16):20H-26H. PubMed ID: 3591711 [Abstract] [Full Text] [Related]
36. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD. J Am Coll Cardiol; 1987 Jan 15; 9(1):169-74. PubMed ID: 3794093 [Abstract] [Full Text] [Related]
37. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease. Volgman AS, Zheutlin TA, Mattioni TA, Parker MA, Kehoe RF. Am J Cardiol; 1992 Sep 15; 70(7):758-63. PubMed ID: 1519526 [Abstract] [Full Text] [Related]
38. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias. Schoenfeld MH, McGovern B, Garan H, Kelly E, Grant G, Ruskin JN. J Am Coll Cardiol; 1985 Aug 15; 6(2):298-306. PubMed ID: 4019918 [Abstract] [Full Text] [Related]
39. Should asymptomatic patients with coronary artery disease and nonsustained ventricular tachycardia be treated with antiarrhythmic drugs? Epstein LM, Scheinman MM. Cardiovasc Clin; 1990 Aug 15; 21(1):79-101; discussion 102-4. PubMed ID: 2199057 [No Abstract] [Full Text] [Related]
40. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Poll DS, Marchlinski FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME. Circulation; 1984 Sep 15; 70(3):451-6. PubMed ID: 6744550 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]